Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hesk

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|August 15, 2019
Highlights of C (sp<sup>2</sup> )-H hydrogen isotope exchange reactionsDavid Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|January 18, 2020
Base metal-catalyzed hydrogen isotope exchangeHaifeng Yang, David Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|January 24, 2015
Synthesis of a [(14) C]-steroid intermediate: an application of a nonstabilized Horner-Wadsworth-Emmons olefination approachNelo R Rivera, Sumei Ren, David Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|September 25, 2014
Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE)Sumei Ren, David Hesk, Paul McNamara, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 24, 2016
Synthesis of [(14) C]omarigliptinSumei Ren, Donald Gauthier, Rosemary Marques, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitorsSumei Ren, David Hesk, Paul McNamara, et al.
Journal of the American Chemical Society|January 30, 2018
A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and PharmaceuticalsJ Luke Koniarczyk, David Hesk, Alix Overgard, et al.
Nature|January 15, 2016
Iron-catalysed tritiation of pharmaceuticalsRenyuan Pony Yu, David Hesk, Nelo Rivera, et al.
Journal of the American Chemical Society|March 5, 2019
Ni(I)-X Complexes Bearing a Bulky α-Diimine Ligand: Synthesis, Structure, and Superior Catalytic Performance in the Hydrogen Isotope Exchange in PharmaceuticalsCayetana Zarate, Haifeng Yang, Máté J Bezdek, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 28, 2015
NMR-based approach to the analysis of radiopharmaceuticals: radiochemical purity, specific activity, and radioactive concentration values by proton and tritium NMR spectroscopyDavid J Schenk, Peter G Dormer, David Hesk, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Labelled Compounds & Radiopharmaceuticals|August 15, 2019
Highlights of C (sp<sup>2</sup> )-H hydrogen isotope exchange reactionsDavid Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|January 18, 2020
Base metal-catalyzed hydrogen isotope exchangeHaifeng Yang, David Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|January 24, 2015
Synthesis of a [(14) C]-steroid intermediate: an application of a nonstabilized Horner-Wadsworth-Emmons olefination approachNelo R Rivera, Sumei Ren, David Hesk
Journal of Labelled Compounds & Radiopharmaceuticals|September 25, 2014
Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE)Sumei Ren, David Hesk, Paul McNamara, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 24, 2016
Synthesis of [(14) C]omarigliptinSumei Ren, Donald Gauthier, Rosemary Marques, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitorsSumei Ren, David Hesk, Paul McNamara, et al.
Journal of the American Chemical Society|January 30, 2018
A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and PharmaceuticalsJ Luke Koniarczyk, David Hesk, Alix Overgard, et al.
Nature|January 15, 2016
Iron-catalysed tritiation of pharmaceuticalsRenyuan Pony Yu, David Hesk, Nelo Rivera, et al.
Journal of the American Chemical Society|March 5, 2019
Ni(I)-X Complexes Bearing a Bulky α-Diimine Ligand: Synthesis, Structure, and Superior Catalytic Performance in the Hydrogen Isotope Exchange in PharmaceuticalsCayetana Zarate, Haifeng Yang, Máté J Bezdek, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 28, 2015
NMR-based approach to the analysis of radiopharmaceuticals: radiochemical purity, specific activity, and radioactive concentration values by proton and tritium NMR spectroscopyDavid J Schenk, Peter G Dormer, David Hesk, et al.
Pageof 4